Eosinophilia induced by interleukin-2 cancer immunotherapy may be associated with enhanced production of total IgE.
Vecchi
L
L
Lissoni
P
P
D000368:Aged; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D004802:Eosinophilia / Q000209:etiology*; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood*; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis
D007376:Interleukin-2; D007073:Immunoglobulin E